Johnson & Johnson (JNJ) Stock Forecast & Price Target
JNJ Analyst Ratings
Moderate Buy
11Buy6Hold0Sell
Based on 17 analysts giving stock ratings to Johnson & Johnson in the past 3 months
JNJ Stock 12 Month Forecast
Average Price Target
MXN 5,378.53▲(4.09% Upside)Based on 17 Wall Street analysts offering 12 month price targets for Johnson & Johnson in the last 3 months. The average price target is MXN 5,378.53 with a high forecast of MXN 5,978.74 and a low forecast of MXN 4,857.72. The average price target represents a 4.09% change from the last price of MXN 5,167.40.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 5.98K
AverageMXN 5.38K
LowMXN 4.86K
Highest Price TargetHighestMXN 5,978.74Average Price TargetMXN 5,378.53Lowest Price TargetLowestMXN 4,857.72
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Trung Huynh | RBC Capital | MXN 5,231.40 | buy | 1.24%Upside | Reiterated | 10/27/26 | ||
| David Risinger | Leerink Partners | MXN 5,081.93 | buy | -1.65%Downside | Reiterated | 10/27/26 | ||
| Louise Chen | Scotiabank | MXN 5,698.48 | buy | 10.28%Upside | Reiterated | 10/26/26 | ||
| Asad Haider | Goldman Sachs | MXN 5,231.40 | buy | 1.24%Upside | Reiterated | 10/26/26 | ||
| Michael Yee | UBS | MXN 5,978.74 | buy | 15.70%Upside | Reiterated | 10/25/26 | ||
| Hans Engel | Erste Group | ― | hold | ― | Downgraded | 10/21/26 | ||
| Chris LoBianco | TD Cowen | MXN 5,605.07 | buy | 8.47%Upside | Assigned | 10/19/26 | ||
| Larry Biegelsen | Wells Fargo | MXN 5,137.98→MXN 5,362.18 | buy | 3.77%Upside | Reiterated | 10/15/26 | ||
| Terence Flynn | Morgan Stanley | MXN 5,492.97→MXN 5,455.60 | buy | 5.58%Upside | Reiterated | 10/15/26 | ||
| Jason Gerberry | Bank of America Securities | MXN 5,137.98 | hold | -0.57%Downside | Reiterated | 10/14/26 | ||
| Lee Hambright | Bernstein | MXN 4,876.41→MXN 5,044.56 | hold | -2.38%Downside | Reiterated | 10/14/26 | ||
| Rick Wise | Stifel Nicolaus | MXN 4,857.72 | hold | -5.99%Downside | Reiterated | 10/12/26 | ||
| Vamil Divan | Guggenheim | MXN 5,362.18 | buy | 3.77%Upside | Reiterated | 10/06/26 | ||
| Joanne Wuensch | Citi | MXN 5,567.70→MXN 5,661.12 | buy | 9.55%Upside | Reiterated | 10/05/26 | ||
| Chris Schott | J.P. Morgan | MXN 5,044.56→MXN 5,324.81 | hold | 3.05%Upside | Reiterated | 09/29/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Trung Huynh | 10/27/26 | MXN 5,231.40 | buy | 1.24%Upside | Reiterated | RBC Capital | ||
| David Risinger | 10/27/26 | MXN 5,081.93 | buy | -1.65%Downside | Reiterated | Leerink Partners | ||
| Louise Chen | 10/26/26 | MXN 5,698.48 | buy | 10.28%Upside | Reiterated | Scotiabank | ||
| Asad Haider | 10/26/26 | MXN 5,231.40 | buy | 1.24%Upside | Reiterated | Goldman Sachs | ||
| Michael Yee | 10/25/26 | MXN 5,978.74 | buy | 15.70%Upside | Reiterated | UBS | ||
| Hans Engel | 10/21/26 | ― | hold | ― | Downgraded | Erste Group | ||
| Chris LoBianco | 10/19/26 | MXN 5,605.07 | buy | 8.47%Upside | Assigned | TD Cowen | ||
| Larry Biegelsen | 10/15/26 | MXN 5,137.98→MXN 5,362.18 | buy | 3.77%Upside | Reiterated | Wells Fargo | ||
| Terence Flynn | 10/15/26 | MXN 5,492.97→MXN 5,455.60 | buy | 5.58%Upside | Reiterated | Morgan Stanley | ||
| Jason Gerberry | 10/14/26 | MXN 5,137.98 | hold | -0.57%Downside | Reiterated | Bank of America Securities | ||
| Lee Hambright | 10/14/26 | MXN 4,876.41→MXN 5,044.56 | hold | -2.38%Downside | Reiterated | Bernstein | ||
| Rick Wise | 10/12/26 | MXN 4,857.72 | hold | -5.99%Downside | Reiterated | Stifel Nicolaus | ||
| Vamil Divan | 10/06/26 | MXN 5,362.18 | buy | 3.77%Upside | Reiterated | Guggenheim | ||
| Joanne Wuensch | 10/05/26 | MXN 5,567.70→MXN 5,661.12 | buy | 9.55%Upside | Reiterated | Citi | ||
| Chris Schott | 09/29/26 | MXN 5,044.56→MXN 5,324.81 | hold | 3.05%Upside | Reiterated | J.P. Morgan |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Johnson & Johnson
3 Months
Success Rate12/15 ratings generated profit
80%
Average Return
+9.40%
Copying Asad Haider's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +9.40% per trade.
1 Year
Success Rate15/15 ratings generated profit
100%
Average Return
+30.95%
Copying Asad Haider's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.95% per trade.
2 Years
Success Rate15/15 ratings generated profit
100%
Average Return
+35.41%
Copying Asad Haider's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.41% per trade.
JNJ Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 26 | 37 | 41 | 44 | 37 |
| Hold | 9 | 8 | 7 | 10 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 35 | 45 | 48 | 54 | 46 |
In the current month, JNJ has received 37 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. JNJ average Analyst price target in the past 3 months is 5,378.53.
JNJ Financial Forecast
HighMXN 54.92
ConsensusMXN 53.85
LowMXN 50.84
JNJ Earnings Forecast
Next quarter’s earnings estimate for JNJ is MXN 53.85 with a range of MXN 50.84 to MXN 54.92. The previous quarter’s EPS was MXN 48.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 495B
ConsensusMXN 490B
LowMXN 487B
JNJ Sales Forecast
Next quarter’s sales forecast for JNJ is MXN 490.10B with a range of MXN 486.67B to MXN 495.09B. The previous quarter’s sales results were MXN 471.29B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
JNJ Stock Forecast FAQ
What is MX:JNJ’s average 12-month price target, according to analysts?
Based on analyst ratings, Johnson & Johnson’s 12-month average price target is Mex$5,378.53.
What is MX:JNJ’s upside potential, based on the analysts’ average price target?
Johnson & Johnson has 4.09% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Johnson & Johnson a Buy, Sell or Hold?
Johnson & Johnson has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 6 hold ratings and 0 sell ratings.
What is Johnson & Johnson’s share price target?
The average share price target for Johnson & Johnson is Mex$5,378.53. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$5,978.74, and the lowest forecast is Mex$4,857.72. The average share price target represents a 4.09% increase from the current price of Mex$5,167.4.
What do analysts say about Johnson & Johnson?
Johnson & Johnson’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Johnson & Johnson?
To buy shares of MX:JNJ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
